Page last updated: 2024-11-01

nifedipine and Zollinger-Ellison Syndrome

nifedipine has been researched along with Zollinger-Ellison Syndrome in 1 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Zollinger-Ellison Syndrome: A syndrome that is characterized by the triad of severe PEPTIC ULCER, hypersecretion of GASTRIC ACID, and GASTRIN-producing tumors of the PANCREAS or other tissue (GASTRINOMA). This syndrome may be sporadic or be associated with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McColl, KE1
Buchanan, NM1
Laferla, G1
Hearns, J1
Buchanan, K1
Crean, GP1

Trials

1 trial available for nifedipine and Zollinger-Ellison Syndrome

ArticleYear
Effects of nifedipine on gastric acid secretion and gastrin release in man.
    Gut, 1987, Volume: 28, Issue:4

    Topics: Adult; Calcium; Clinical Trials as Topic; Double-Blind Method; Gastric Acid; Gastrins; Humans; Male;

1987